A new study has found that for people seeking a natural treatment for the common cold, some preparations containing the plant Echinacea work better than nothing, yet "evidence is weak".
The evidence review revealed no significant reductions in preventing illness, but didn't rule out "small preventive effects."
The six authors conducted reviews on this subject in 1998, 2006 and 2008 and wanted to do an update to include several new trials conducted since then.
"We've been doing this for so long and are very familiar with past research- which has been mixed from the very beginning," author Bruce Barrett, M.D., Ph.D. in the department of family medicine at the University of Wisconsin in Madison, said.
The research team reviewed 24 randomized controlled trials to determine whether Echinacea was a safe and effective cold prevention and treatment.
Trials included 4631 participants and 33 preparations, along with placebo. Echinacea products studied in these trials varied widely according to characteristics of three different plant species, the part of the plant used and method of manufacturing.
Barrett added that "it looks like taking Echinacea may reduce the incidence of colds. For those who take it as a treatment, some of the trials report real effects-but many do not. Bottom line: Echinacea may have small preventive or treatment effects, but the evidence is mixed."
The study was published in the journal Cochrane Library.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
